Generate Biomedicines, Inc.
PricedNASDAQ Global Select: GENB
Generate Biomedicines, Inc. IPO
Monitoring
S-1 Filed
Priced
Trading
Offering size
$400M
Range: 16.00
Exchange
NASDAQ Global Select
Ticker: GENB
Status
Priced
IPO date
Feb 27, 2026
FireStrike Analysis
FireStrike is tracking the Generate Biomedicines, Inc. IPO. Analysis and commentary will appear here as filings, roadshow details, and pricing information become available. Subscribe to the daily brief to get updates the morning they happen.
Frequently asked questions
When is Generate Biomedicines, Inc. going public?
Generate Biomedicines, Inc. has been priced and is expected to begin trading on Feb 27, 2026.
What is Generate Biomedicines, Inc.'s IPO valuation?
The estimated offering value is $400M, with a preliminary price range of 16.00. Final valuation will be determined at pricing.
What exchange will Generate Biomedicines, Inc. list on?
Generate Biomedicines, Inc. is expected to be listed on the NASDAQ Global Select. The ticker symbol is GENB.
Has Generate Biomedicines, Inc. filed an S-1 with the SEC?
No. As of the most recent data, Generate Biomedicines, Inc. has not filed a Form S-1 or other registration statement with the SEC.
Sources: FireStrike proprietary index · SEC EDGAR